[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"PharmaEssentia Japan K.K.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":41},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100412787",false,"NCT04655092","Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients","Extension Study of P1101 in Japanese Patients Who Have Completed Phase 2 Single Arm Study in Polycythemia Vera (PV) Patients (Study A19-201) or Phase 3 Study in Essential Thrombocythemia (ET) Patients (Study P1101 ET)","Inclusion Criteria:\n\n* Patients who have completed the 52-week treatment duration in Study A19-201 and are considered by the investigator or sub investigator to be eligible for participation in this study\n* Patients who have given written informed consent to participate in this study\n\nExclusion Criteria:\n\n* Patients who are considered by the investigator or sub investigator to be ineligible for continued treatment with P1101","ALL","20 Years",{"count":18,"type":19},67,"ESTIMATED","INTERVENTIONAL",[22],"PHASE3","This is a Phase 3 open-label, multicenter, single arm study designed to evaluate the efficacy and safety and tolerability of P1101 patient with PV or ET in long-term.",[25],"Polycythemia Vera (PV)",[27],"Myeloproliferative Neoplasms","RECRUITING","2024-11-06",{"date":31,"type":32},"2024-11-08","ACTUAL",{"date":34,"type":32},"2021-01-19",{"date":36,"type":19},"2026-06-30",{"name":38,"class":39},"PharmaEssentia Japan K.K.","INDUSTRY",6,""]